Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05721859 · ClinicalTrials.gov registry record
M-Vizion™ Macroscopic Radiographic Study
A clinical trial of Revision Hip Arthroplasty, sponsored by Medacta U.
- Recruiting
- Registry status
- 70
- Enrollment target
- 7
- Study locations
NCT05721859: Recruiting study of Revision Hip Arthroplasty, sponsored by Medacta U.
NCT05721859 is a study of Revision Hip Arthroplasty that is actively recruiting participants, run by Medacta U. The registered enrollment target is 70 participants. The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05721859, a study of Revision Hip Arthroplasty, is actively recruiting participants, sponsored by Medacta U.
- RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 7
- Study locations
Study Summary
Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.
Primary Outcome
Occurrence of subsidence \>5mm
Conditions Studied
Interventions
- DEVICE revision hip arthroplasty
Study Locations (7)
Massachusetts
- New England Baptist Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Illinois
- Northwestern Medicine - Chicago
New Hampshire
- Dartmouth Health - Lebanon
North Carolina
- OrthoCarolina Research Institute, Inc. - Charlotte
Pennsylvania
- Geisinger Medical Center - Danville
Utah
- University of Utah Department of Orthopaedics - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2022-10-12 |
| Est. Completion | 2026-06-01 |
What NCT05721859 shows while recruiting
NCT05721859 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 1 condition, with Revision Hip Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which revision hip arthroplasty is the first listed.
NCT05721859 lists 7 locations in 6 states (Massachusetts, Illinois, New Hampshire).
Frequently Asked Questions
What is clinical trial NCT05721859 about?
NCT05721859 is a clinical study titled "M-Vizion™ Macroscopic Radiographic Study". Study of the patient's subsidence after revision hip arthroplasty by assessing gross stem subsidence in the femoral canal.
What is the current status of trial NCT05721859?
This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2022-10-12. Estimated completion is 2026-06-01.
What conditions does trial NCT05721859 study?
This clinical trial studies the following conditions: Revision Hip Arthroplasty.
What interventions are being tested in trial NCT05721859?
The interventions under investigation include: revision hip arthroplasty (DEVICE).
Who is sponsoring clinical trial NCT05721859?
This trial is sponsored by Medacta U, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05721859 being conducted?
This trial has 7 study locations across Illinois, Massachusetts, New Hampshire, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI